Sophie Fédrizzi

1.2k total citations · 1 hit paper
49 papers, 727 citations indexed

About

Sophie Fédrizzi is a scholar working on Toxicology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Sophie Fédrizzi has authored 49 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Toxicology, 13 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in Sophie Fédrizzi's work include Pharmacovigilance and Adverse Drug Reactions (15 papers), Drug-Induced Adverse Reactions (11 papers) and Sodium Intake and Health (5 papers). Sophie Fédrizzi is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (15 papers), Drug-Induced Adverse Reactions (11 papers) and Sodium Intake and Health (5 papers). Sophie Fédrizzi collaborates with scholars based in France, Italy and New Zealand. Sophie Fédrizzi's co-authors include Joachim Alexandre, Basile Chrétien, Marion Sassier, Charles Dolladille, Véronique Lelong‐Boulouard, Angélique Da Silva, P Milliez, Damien Legallois, Stéphane Éderhy and Ariel Cohen and has published in prestigious journals such as Neurology, Annals of Neurology and Scientific Reports.

In The Last Decade

Sophie Fédrizzi

40 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

2020 377 citations Charles Dolladille, Marion Sassier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie Fédrizzi France	13	358	172	82	76	73	49	727
Takahiro Niimura Japan	13	207 0.6×	134 0.8×	38 0.5×	85 1.1×	57 0.8×	67	517
Diogo Mendes Portugal	16	129 0.4×	68 0.4×	66 0.8×	116 1.5×	100 1.4×	40	796
Jianhong Zhu China	10	136 0.4×	174 1.0×	25 0.3×	85 1.1×	85 1.2×	43	546
Stefania Mantarro Italy	11	201 0.6×	75 0.4×	30 0.4×	52 0.7×	61 0.8×	17	470
Josephina G. Kuiper Netherlands	13	182 0.5×	110 0.6×	29 0.4×	63 0.8×	87 1.2×	37	640
Louise Stanton United Kingdom	15	443 1.2×	138 0.8×	39 0.5×	87 1.1×	88 1.2×	36	856
Didem Şener Dede Türkiye	13	286 0.8×	160 0.9×	65 0.8×	94 1.2×	80 1.1×	50	768
Anne B. Taegtmeyer Switzerland	16	125 0.3×	130 0.8×	46 0.6×	163 2.1×	105 1.4×	50	709
Ronald J. Maggiore United States	21	532 1.5×	330 1.9×	40 0.5×	87 1.1×	149 2.0×	46	1.2k
Abdulaali R. Almutairi Saudi Arabia	11	189 0.5×	82 0.5×	53 0.6×	72 0.9×	89 1.2×	48	597

Countries citing papers authored by Sophie Fédrizzi

Since Specialization

Citations

This map shows the geographic impact of Sophie Fédrizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Fédrizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Fédrizzi more than expected).

Fields of papers citing papers by Sophie Fédrizzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Fédrizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Fédrizzi. The network helps show where Sophie Fédrizzi may publish in the future.

Co-authorship network of co-authors of Sophie Fédrizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Fédrizzi. A scholar is included among the top collaborators of Sophie Fédrizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Fédrizzi. Sophie Fédrizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morice, Alyn H., Pierre‐Marie Morice, Joachim Alexandre, et al.. (2025). Risk of thyroid cancer related to glucagon‐like peptide‐1 receptor agonists: A systematic review with meta‐analysis of harms of randomized controlled trials. Diabetes Obesity and Metabolism. 27(8). 4607–4610. 2 indexed citations

Chrétien, Basile, Perrine Brazo, Angélique Da Silva, et al.. (2023). Infections associated with clozapine: a pharmacovigilance study using VigiBase®. Frontiers in Pharmacology. 14. 1260915–1260915. 5 indexed citations

Bihan, Kévin, et al.. (2023). Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022. Therapies. 78(5). 531–547. 9 indexed citations

Humbert, Xavier, Sophie Fédrizzi, Alessandro Menotti, et al.. (2023). Marital status and long-term cardiovascular risk in general population (Gubbio, Italy). Scientific Reports. 13(1). 6723–6723. 6 indexed citations

Fédrizzi, Sophie, et al.. (2023). Validation of a method for detecting hospitalizations for falls related to adverse drug reactions in geriatric departments. PubMed. 21(4). 437–446.

Dolladille, Charles, Basile Chrétien, Sophie Fédrizzi, et al.. (2022). Neonatal Hypotonia Following in Utero Exposure to Antidepressant Drugs. The Journal of Pediatrics. 245. 222–226.e2. 3 indexed citations

Dolladille, Charles, Basile Chrétien, Laure Peyro‐Saint‐Paul, et al.. (2021). Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis. Neurotherapeutics. 18(3). 1657–1664. 24 indexed citations

Peyro‐Saint‐Paul, Laure, Sophie Fédrizzi, & Gilles Defer. (2021). Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management. Revue Neurologique. 177(5). 582–588.

Chrétien, Basile, Véronique Lelong‐Boulouard, Sylvain Chantepie, et al.. (2020). Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase^®. Psychological Medicine. 51(9). 1459–1466. 27 indexed citations

10.

Humbert, Xavier, Sophie Fédrizzi, Emmanuel Touzé, Joachim Alexandre, & Paolo Emilio Puddu. (2019). White-coat hypertension: management and adherence to guidelines by European and Canadian GPs. A cross-sectional clinical vignette study. BJGP Open. 3(4). bjgpopen19X101664–bjgpopen19X101664. 3 indexed citations

11.

Humbert, Xavier, Sophie Fédrizzi, Joachim Alexandre, et al.. (2019). Impact of Sex on Office White Coat Effect Tail: Investigating Two Italian Residential Cohorts. Scientific Reports. 9(1). 17237–17237. 5 indexed citations

12.

Petitpain, Nadine, Kamel Masmoudi, Sophie Fédrizzi, et al.. (2018). Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012. Allergy. 73(11). 2224–2233. 30 indexed citations

13.

Dolladille, Charles, Xavier Humbert, Marion Sassier, et al.. (2018). Association between venous thromboembolism events and fibrates: A comparative study. Therapies. 74(3). 421–430. 3 indexed citations

14.

Sassier, Marion, B. Mennecier, Antoine Coquerel, et al.. (2016). Successful treatment with ceritinib after crizotinib induced hepatitis. Lung Cancer. 95. 15–16. 12 indexed citations

15.

Humbert, Xavier, Vincent Roule, Sophie Fédrizzi, et al.. (2016). Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease. International Journal of Cardiology. 222. 1079–1083. 10 indexed citations

16.

Fédrizzi, Sophie, Sabrina Crépin, Jean‐Jacques Parienti, et al.. (2016). Sécurité des essais cliniques : accompagnement de l’investigateur par le vigilant pour la publication des données de sécurité. Une ligne directrice du groupe REVISE. Therapies. 71(5). 475–481. 1 indexed citations

17.

Alexandre, Joachim, Xavier Humbert, Marion Sassier, et al.. (2015). High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?. PubMed. 2(1). 13–13. 8 indexed citations

18.

Mouriaux, F., et al.. (2015). Effets indésirables graves liés à la dilatation pupillaire chez le prématuré. Journal Français d Ophtalmologie. 38(3). 193–198. 7 indexed citations

19.

Fédrizzi, Sophie, et al.. (2015). Pseudo-phéochromocytome médicamenteux sous iproniazide : à propos d’un cas. La Revue de Médecine Interne. 37(2). 135–138. 1 indexed citations

20.

Peyro‐Saint‐Paul, Laure, et al.. (2014). Nouvel effet indésirable fréquent des inhibiteurs de la pompe à protons chez le sujet âgé : l’hyponatrémie modérée. Therapies. 69(2). 157–162. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact